Related Experiment Video
Updated: Jan 3, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
The Effect of Advance Care Planning on Heart Failure: a Systematic Review and Meta-analysis
Markus Schichtel1, Bee Wee2, Rafael Perera3
1Department of Public Health and Primary Care, Primary Care Unit, University of Cambridge, Cambridge, UK. ms2591@medschl.cam.ac.uk.
Insights
Advance care planning (ACP) significantly improves quality of life, patient satisfaction, and end-of-life communication for heart failure patients. Optimal effectiveness is achieved through timely introduction, family involvement, and personalized follow-up.
Area of Science:
- Cardiology
- Palliative Care
- Health Services Research
Background:
- Advance care planning (ACP) is recommended for improving end-of-life care in heart failure patients.
- A systematic evaluation of ACP's impact on clinical outcomes was previously lacking.
- This study aimed to assess the effect of ACP in heart failure via a meta-analysis of randomized controlled trials (RCTs).
Purpose of the Study:
- To systematically evaluate the impact of advance care planning (ACP) on clinical outcomes in heart failure patients.
- To synthesize evidence from randomized controlled trials (RCTs) on the effectiveness of ACP in heart failure management.
- To identify factors influencing the effectiveness of ACP in improving patient outcomes.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (CINAHL, Cochrane, Embase, MEDLINE, etc.) up to July 2018.
- Fourteen RCTs involving 2924 adult heart failure patients were included.
- Data were extracted, risk of bias and evidence quality were assessed using Cochrane and GRADE tools, and pooled effects were calculated using random-effects models.
Main Results:
- ACP demonstrated a moderate positive effect on quality of life (SMD, 0.38) and patient satisfaction with end-of-life care (SMD, 0.39).
- A significant improvement was observed in the quality of end-of-life communication (SMD, 0.29).
- ACP was most effective when initiated at key disease milestones, included family, involved follow-up, and considered ethnic preferences.
Conclusions:
- Advance care planning (ACP) positively impacts quality of life, patient satisfaction, and communication quality in heart failure patients.
- The effectiveness of ACP is enhanced by strategic timing, family engagement, consistent follow-up, and cultural sensitivity.
- ACP is a valuable intervention for improving end-of-life care experiences in individuals with heart failure.
Background:
Advance care planning is widely advocated to improve outcomes in end-of-life care for patients suffering from heart failure. But until now, there has been no systematic evaluation of the impact of advance care planning (ACP) on clinical outcomes. Our aim was to determine the effect of ACP in heart failure through a meta-analysis of randomized controlled trials (RCTs).
Methods:
We searched CINAHL, Cochrane Central Register of Controlled Trials, Database of Systematic Reviews, Embase, ERIC, Ovid MEDLINE, Science Citation Index and PsycINFO (inception to July 2018). We selected RCTs including adult patients with heart failure treated in a hospital, hospice or community setting. Three reviewers independently screened studies, extracted data, assessed the risk of bias (Cochrane risk of bias tool) and evaluated the quality of evidence (GRADE tool) and analysed interventions according to the Template for Intervention Description and Replication (TIDieR). We calculated standardized mean differences (SMD) in random effects models for pooled effects using the generic inverse variance method.
Results:
Fourteen RCTs including 2924 participants met all of the inclusion criteria. There was a moderate effect in favour of ACP for quality of life (SMD, 0.38; 95% CI [0.09 to 0.68]), patients' satisfaction with end-of-life care (SMD, 0.39; 95% CI [0.14 to 0.64]) and the quality of end-of-life communication (SMD, 0.29; 95% CI [0.17 to 0.42]) for patients suffering from heart failure. ACP seemed most effective if it was introduced at significant milestones in a patient's disease trajectory, included family members, involved follow-up appointments and considered ethnic preferences. Several sensitivity analyses confirmed the statistically significant direction of effect. Heterogeneity was mainly due to different study settings, length of follow-up periods and compositions of ACP.
Conclusions:
ACP improved quality of life, patient satisfaction with end-of-life care and the quality of end-of-life communication for patients suffering from heart failure and could be most effective when the right timing, follow-up and involvement of important others was considered.
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure VI: Adjunct Therapies

